4 Amendments of Jens GEIER related to 2011/2220(DEC)
Amendment 1 #
Proposal for a decision 1
Citation 11 a (new)
Citation 11 a (new)
- having regard to the Joint Statement and Common Approach adopted (in June 2012) by the European Parliament, the Council and the Commission, resulting from the work of the Inter Institutional Working Group on decentralised agencies, and in particular the sections on governance, operations, programming, accountability and transparency,
Amendment 2 #
Proposal for a decision 1
Paragraph 1
Paragraph 1
1. ...Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2010;
Amendment 33 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. ENotes that 80% of the Agency's budget derives from fees on services requested by the pharmaceutical sector and notes that the speed of these payments is variable and out of the Agency's control, nevertheless establishes from the Agency's Report on budgetary and financial management that in 2010, there was a cancellation rate of 4,35% of final appropriations totalling EUR 9 074 296,49 were cancelled compared with EUR 7 693 276,58 in 2009; notes the Agency's reply that the level of cancelled expenditure appropriations is a result of stringent monitoring of actual revenue and adjustments to expenditure; urgalso notes the Agency to take immediate's action to reduce thimprove fee lrevel of cancelled appropriations and to adopt an Action Plan with concrete measures - including aimed at a stricter estimation of the fee income and the period to be received - and deadlines to address this persistent problem by 30 June 2012nue forecasting and thereby reduce the level of cancelled appropriations in the future;
Amendment 70 #
Motion for a resolution
Paragraph 34
Paragraph 34
34. Is nevertheless concerned byNotes that the Agency's approach vis- à-vis the scrutiny of declarations of interest, which is primarily based on trust rather than on verification; is notably concerned by the fact that the comparison of the experts' declaration of interest published by the relevant national agencies and by the Agency reveals significant discrepancies in some cases; has been strengthened to include ex-post cross checks on their correctness, and also a breach-of-trust procedure, and furtherefmore calls on the Agency to establish a genuine mechanism enabling proper scrutiny of the declarations of interest received by the Agency and to inform the discharge authority on this matter by 30 June 2012looks forward to receiving information about the implementation of these new aspects;